Literature DB >> 19601903

Antimicrobial peptides and viral fusion peptides: how different they are?

P Joanne1, P Nicolas, C El Amri.   

Abstract

Similarly to antimicrobial peptides (AMPs), viral fusion peptides (FPs) are membrane-active peptides. This minireview emphasizes the common properties of AMPs and FPs with a special focus on the intrinsic flexibility and structural adaptability of these peptides that are responsible for different mode of interaction with the membrane bilayers. The potential use of AMPs as multifunctional drugs with both antibacterial and antiviral properties is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19601903     DOI: 10.2174/092986609788681814

Source DB:  PubMed          Journal:  Protein Pept Lett        ISSN: 0929-8665            Impact factor:   1.890


  8 in total

Review 1.  Exploiting endocytosis for nanomedicines.

Authors:  Akin Akinc; Giuseppe Battaglia
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-11-01       Impact factor: 10.005

2.  Assessment of RNA carrier function in peptide amphiphiles derived from the HIV fusion peptide.

Authors:  Yaowalak Pratumyot; Oscar B Torres; Dennis Bong
Journal:  Peptides       Date:  2016-03-15       Impact factor: 3.750

Review 3.  Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs.

Authors:  Sabrina Riedl; Dagmar Zweytick; Karl Lohner
Journal:  Chem Phys Lipids       Date:  2011-09-16       Impact factor: 3.329

4.  Antimicrobial and cell-penetrating peptides induce lipid vesicle fusion by folding and aggregation.

Authors:  Parvesh Wadhwani; Johannes Reichert; Jochen Bürck; Anne S Ulrich
Journal:  Eur Biophys J       Date:  2011-11-12       Impact factor: 1.733

Review 5.  Membranotropic Cell Penetrating Peptides: The Outstanding Journey.

Authors:  Annarita Falanga; Massimiliano Galdiero; Stefania Galdiero
Journal:  Int J Mol Sci       Date:  2015-10-23       Impact factor: 5.923

6.  Peptide-lipid interactions: experiments and applications.

Authors:  Stefania Galdiero; Annarita Falanga; Marco Cantisani; Mariateresa Vitiello; Giancarlo Morelli; Massimiliano Galdiero
Journal:  Int J Mol Sci       Date:  2013-09-12       Impact factor: 5.923

Review 7.  Model membrane platforms for biomedicine: case study on antiviral drug development.

Authors:  Joshua A Jackman; Nam-Joon Cho
Journal:  Biointerphases       Date:  2012-02-11       Impact factor: 2.456

Review 8.  gH625: a milestone in understanding the many roles of membranotropic peptides.

Authors:  Stefania Galdiero; Annarita Falanga; Giancarlo Morelli; Massimiliano Galdiero
Journal:  Biochim Biophys Acta       Date:  2014-10-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.